现在GLP-1药品价格更便宜,但对许多病人和系统来说仍然太昂贵。 GLP-1 drugs now cheaper, but still too costly for many patients and systems.

医生们欢迎最近用于治疗肥胖症和2型糖尿病的GLP-1型药品的价格降低, Doctors welcome recent price reductions for GLP-1 drugs used to treat obesity and type 2 diabetes, calling them a positive step toward greater access. 然而,他们告诫说,对于许多病人和保健系统来说,目前的费用仍然高得令人望而却步,从而限制了长期可持续性和广泛使用。 However, they caution that current costs remain prohibitively high for many patients and healthcare systems, limiting long-term sustainability and widespread use.